Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
Thrombotic microangiopathy associated with use of interferon-beta.
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
Characterization of CD56bright NK cells in daclizumab HYP-treated RRMS patients
Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
New Drugs Online report for idebenone
Alemtuzumab and multiple sclerosis: therapeutic application.
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.
Ustekinumab success in refractory Crohn’s disease
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Daclizumab Therapy for Multiple Sclerosis.
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.
Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish.
Adaptive myelination from fish to man.
Ethnicity and prevalence of multiple sclerosis in east London.
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Cognitive impairment in multiple sclerosis.
Klotho Is a Neuroprotective and Cognition-Enhancing Protein.
Multiple Sclerosis and Pregnancy: Current Considerations.

Pages